Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Outset Medical (OM) Net Margin (2019 - 2026)

Outset Medical has reported Net Margin over the past 7 years, most recently at 67.5% for Q4 2025.

  • Quarterly Net Margin rose 1950.0% to 67.5% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 68.34% through Dec 2025, up 4422.0% year-over-year, with the annual reading at 68.34% for FY2025, 4422.0% up from the prior year.
  • Net Margin was 67.5% for Q4 2025 at Outset Medical, down from 60.61% in the prior quarter.
  • Over five years, Net Margin peaked at 59.01% in Q2 2025 and troughed at 174.96% in Q2 2022.
  • The 5-year median for Net Margin is 124.01% (2024), against an average of 117.16%.
  • The largest YoY upside for Net Margin was 19168bps in 2021 against a maximum downside of -18889bps in 2021.
  • A 5-year view of Net Margin shows it stood at 146.46% in 2021, then rose by 12bps to 129.48% in 2022, then grew by 2bps to 126.53% in 2023, then soared by 31bps to 87.01% in 2024, then increased by 22bps to 67.5% in 2025.
  • Per Business Quant, the three most recent readings for OM's Net Margin are 67.5% (Q4 2025), 60.61% (Q3 2025), and 59.01% (Q2 2025).